Entero Therapeutics, Inc./$GRDX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Entero Therapeutics, Inc.
GridAI Technologies Corp, formerly known as Entero Therapeutics Inc, is a late clinical-stage biopharmaceutical company focused on the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. The company's programs address unmet needs in GI health and include: latiglutenase, a Phase 3-ready, potentially first-in-class, targeted, oral biotherapeutic for celiac disease; capeserod, a selective 5-HT4 receptor partial agonist for indications including gastroparesis; and adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients in cystic fibrosis and chronic pancreatitis patients with exocrine pancreatic insufficiency.
Ticker
$GRDX
Sector
Primary listing
Employees
-
Headquarters
Website
GRDX Metrics
BasicAdvanced
$19m
-
-
-
-
Price and volume
Market cap
$19m
52-week high
$6.93
52-week low
$1.65
Average daily volume
69k
Financial strength
Profitability
Management effectiveness
Valuation
Growth
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.